Evidence map›Paper›PMID 31003928›Full record

ArticleEBioMedicine2019

Deep learning only by normal brain PET identify unheralded brain anomalies.

Hongyoon Choi, Seunggyun Ha, Hyejin Kang, Hyekyoung Lee, Dong Soo Lee, Alzheimer's Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in EBioMedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Real-world comparison of brain [EClinicalMedicine · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Brainomaly: Unsupervised Neurologic Disease Detection Utilizing Unannotated T1-weighted Brain MR Images.IEEE Winter Conference on Applications of Computer Vision. IEEE Winter Conference on Applications of Computer Vision · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The transformational potential of molecular radiomics.Journal of medical radiation sciences · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Artificial intelligence for molecular neuroimaging.Annals of translational medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hongyoon ChoiDepartment of Nuclear Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Seunggyun HaDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Hyejin KangDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Hyekyoung LeeDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Dong Soo LeeDepartment of Nuclear Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea. Electronic address: dsl@plaza.snu.ac.kr.
Alzheimer's Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

backgroundRecent deep learning models have shown remarkable accuracy for the diagnostic classification. However, they have limitations in clinical application due to the gap between the training cohorts and real-world data. We aimed to develop a model trained only by normal brain PET data with an unsupervised manner to identify an abnormality in various disorders as imaging data of the clinical routine.

methodsUsing variational autoencoder, a type of unsupervised learning, Abnormality Score was defined as how far a given brain image is from the normal data. The model was applied to FDG PET data of Alzheimer's disease (AD) and mild cognitive impairment (MCI) and clinical routine FDG PET data for assessing behavioral abnormality and seizures. Accuracy was measured by the area under curve (AUC) of receiver-operating-characteristic (ROC) curve. We investigated whether deep learning has additional benefits with experts' visual interpretation to identify abnormal patterns.

findingsThe AUC of the ROC curve for differentiating AD was 0.90. The changes in cognitive scores from baseline to 2-year follow-up were significantly correlated with Abnormality Score at baseline. The AUC of the ROC curve for discriminating patients with various disorders from controls was 0.74. Experts' visual interpretation was helped by the deep learning model to identify abnormal patterns in 60% of cases initially not identified without the model.

interpretationWe suggest that deep learning model trained only by normal data was applicable for identifying wide-range of abnormalities in brain diseases, even uncommon ones, proposing its possible use for interpreting real-world clinical data.

Indexed as

Deep LearningPositron-Emission TomographyAlzheimer DiseaseArea Under CurveBrainBrain DiseasesCognitive DysfunctionFluorodeoxyglucose F18HumansImage Processing, Computer-AssistedNeuroimagingROC CurveFluorodeoxyglucose F18AlzheimerAnomaly detectionDeep learningPETVariational autoencoder

Identifiers

PMID31003928
PMCPMC6557913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.